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Neurovascular EGFL7 regulates adult neurogenesis
in the subventricular zone and thereby affects
olfactory perception
Frank Bicker1,2, Verica Vasic1,2, Guilherme Horta1,2,3, Felipe Ortega2,4,5, Hendrik Nolte6, Atria Kavyanifar1,2,
Stefanie Keller1,2, Nevenka Dudvarski Stankovic1,2, Patrick N. Harter7, Rui Benedito8, Beat Lutz2,4,
Tobias Ba¨uerle9, Jens Hartwig10, Jan Baumgart1,2,3, Marcus Kru¨ger6, Konstantin Radyushkin1,2,3, Lavinia Alberi11,12,
Benedikt Berninger2,4 & Mirko H.H. Schmidt1,2
Adult neural stem cells reside in a specialized niche in the subventricular zone (SVZ).
Throughout life they give rise to adult-born neurons in the olfactory bulb (OB), thus
contributing to neural plasticity and pattern discrimination. Here, we show that the
neurovascular protein EGFL7 is secreted by endothelial cells and neural stem cells (NSCs) of
the SVZ to shape the vascular stem-cell niche. Loss of EGFL7 causes an accumulation
of activated NSCs, which display enhanced activity and re-entry into the cell cycle.
EGFL7 pushes activated NSCs towards quiescence and neuronal progeny towards
differentiation. This is achieved by promoting Dll4-induced Notch signalling at the blood
vessel-stem cell interface. Fewer inhibitory neurons form in the OB of EGFL7-knockout mice,
which increases the absolute signal conducted from the mitral cell layer of the OB but
decreases neuronal network synchronicity. Consequently, EGFL7-knockout mice display
severe physiological defects in olfactory behaviour and perception.
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eural stem cells (NSCs) reside in a specialized micro-
environment that maintains them as undifferentiated
quiescent cells (qNSCs) but allows them to re-enter the
cell cycle upon stimulation and become activated (aNSCs) to
sustain life-long regeneration of the neuronal population1–3. The
subventricular zone (SVZ) is one of two germinal niches of the
adult mammalian brain where NSCs reside and give rise to new
neurons throughout life. This process of neurogenesis is initiated
from type B qNSCs that, upon activation, turn into aNSCs and
give rise to type C transit-amplifying progenitors (TAPs). TAPs
become type A neuroblasts (NBs) and migrate along the rostral
migratory stream (RMS) to the olfactory bulb (OB) where they
eventually differentiate into inhibitory interneurons4. In the
mouse, function and structure of the OB heavily rely on this
constant inﬂux of adult-born neurons, which form various types
of interneurons5 and contribute to neural plasticity of olfactory
information processing and pattern discrimination6. Adult NSCs
display a characteristic morphology that allows them to bridge
the three layers of the SVZ7. NSCs come into contact with the
cerebrospinal ﬂuid by an apical process, with their progeny by
their intermediate segment and associate with blood vessels by a
basal endfoot8.
The molecular cues governing NSC maintenance, neurogenesis
and the role of blood vessels in this context have not been fully
explored but it has been demonstrated that NSCs exist in a
specialized vascular niche, where the regulation of NSCs in SVZ
relies on the local vasculature9,10 and the cerebrospinal ﬂuid11.
However, only a few blood vessel-derived factors regulating
NSCs have been identiﬁed, such as VEGF12,13, NT-3 (ref. 14),
betacellulin15, PEDF16, PlGF-2 (ref. 17) or the Notch ligand Jagged1
(ref. 18). Notch pathway components are broadly expressed
throughout the brain and are particularly active in SVZ
NSCs4,19,20. Notch receptors share a common architecture and
are activated by canonical Delta- or Jagged-type ligands by speciﬁc
EGF repeats by a series of cleavage events, which eventually release
the Notch intracellular domain and activates the transcription
factor RBPJ21. A putative blood vessel-derived Notch modulator
acting in this context is the epidermal growth factor-like protein 7
(EGFL7), which has been identiﬁed as a non-canonical Notch
ligand and inhibitor of Jagged-induced Notch signalling in NSCs
in vitro22. Further, EGFL7 has been shown to be secreted by
neurons and blood vessels in the adult brain23,24.
In this work the potential of EGFL7 to act as an angioneurin
governing NSCs in vivo is elicited. We show where the protein is
localized in the SVZ, how it governs NSCs in vivo and unravel its
function for olfactory perception in the OB
Results
Localization of EGFL7 expression in the mouse brain and SVZ.
To deﬁne the temporal and spatial expression of EGFL7 in
embryonic development, RNA was isolated from murine embryos
at various stages ranging from embryonic day 9 (E9) to E18 as the
latest stage. The expression levels of EGFL7 were compared by
quantitative reverse transcriptase-polymerase chain reaction
(qRT-PCR). EGFL7 expression peaked at E9 (Fig. 1a), when
embryonic blood vessel formation reaches a maximum and was
restricted to vascular structures (Fig. 1b–d and Supplementary
Fig. 1a–i). Another wave of EGFL7 expression was observed at
E18 (Fig. 1a) when the ﬁrst non-vascular cells were spotted in the
marginal zone of the developing brain (Supplementary Fig. 1j–l).
Morphology, shape and local distribution identiﬁed these cells as
Cajal–Retzius neurons (Supplementary Fig. 1k). In late prenatal
and various postnatal stages a continuously rising level of EGFL7
was observed, lasting until adulthood at postnatal stage P40
(Fig. 1e). Subsequently, the expression levels declined but
remained stable at signiﬁcant levels until high age. In situ and
ﬂuorescence in situ hybridization (FISH) revealed the overall high
expression of EGFL7 in neurons throughout the brain, for
example, in the cortex (Fig. 1f–h) but lower EGFL7 levels in the
SVZ (Supplementary Fig. 1m–q). Nevertheless, EGFL7 was
detected in vascular (Supplementary Fig. 1n–p, arrowheads) and
non-vascular (Supplementary Fig. 1n–p, asterisks) structures.
Interestingly, the RMS (Supplementary Fig. 1r, region inside the
dotted line), which NBs utilize to exit the SVZ and to migrate
towards differentiation into the OB, was fully devoid of an EGFL7
signal, while the striatum surrounding the RMS (Supplementary
Fig. 1r, region surrounding the dotted line) and the OB
(Supplementary Fig. 1s,t) displayed distinct EGFL7 signals.
EGFL7-expressing cells in the SVZ were visualized by a
combination of FISH, using EGFL7-speciﬁc probes, and
immunoﬂuorescence (IF) to identify speciﬁc cell types. Strong
EGFL7 expression was detected in ECs (Fig. 1i,j, arrowheads)
and aNSCs/NPCs (Fig. 1k,l, arrowheads). In addition, EGFL7
expression was sporadically detected in TAPs (Supplementary
Fig. 1u) and in neuronal projections (Supplementary Fig. 1v). NBs
(Supplementary Fig. 1w), Eps (Supplementary Fig. 1x) and astrocytes
(Fig. 1l, arrows; Supplementary Fig. 1y) stained negative for EGFL7.
To quantitatively compare EGFL7 levels in different SVZ cell
types, these were isolated by ﬂuorescence-activated cell sorting
(FACS). qRT-PCR revealed that ECs and qNSCs synthesized
particularly high levels of EGFL7 (Fig. 1m). Smaller amounts
were traced in aNSCs and TAPs, but no expression was detected
in NBs, Eps or astrocytes. Considering the excess of ECs over
NSCs (410:1 as determined by FACS sorting), blood vessels
seem to be the major source of EGFL7 in the SVZ.
EGFL7 affected SVZ-derived neurospheres. The functional
impact of EGFL7 on NSCs/NPCs in vitro was analysed in
SVZ-derived neurospheres by assessment of the amount of
secondary formed spheres (self-renewal) and sphere size. An
adenoviral approach was applied to ectopically express EGFL7 in
infected spheres at an early phase of sphere formation (Fig. 2a).
Comparable viral infection rates were monitored by enhanced
green ﬂuorescent protein (EGFP) expression and FACS
(Supplementary Fig. 2a,b). Furthermore, it has been veriﬁed
that neurosphere assays performed at clonal density or under
clonal conditions upon FACS sort yielded comparable results
(Supplementary Fig. 2c). The self-renewal potential of neuro-
spheres was signiﬁcantly reduced upon the ectopic expression of
EGFL7 using AdEGFL7 (Supplementary Fig. 2d). Further,
EGFL7-infected spheres were smaller (Fig. 2b; o20 mm) and
proliferated less as quantiﬁed by qRT-PCR of the proliferation
markers Ki67 and MCM2 (Supplementary Fig. 2e) as previously
described22. Data indicate that EGFL7-infected spheres
failed to overcome the single/few cell state. Conversely,
EGFL7 / spheres displayed an increased self-renewal
potential (Supplementary Fig. 2f), conﬁrming previous
knockdown approaches22. Furthermore, EGFL7 / spheres
grew larger (Fig. 2c; 475 mm) and displayed enhanced
proliferation (Supplementary Fig. 2g).
Proteomics analyses of EGFL7 / and wild-type (WT)
neurospheres by SILAC-based mass spectrometry25 at day (d) 2
and d5 post seeding, using Lys(6)-labelled mouse lysates as an
internal spike-in protein standard (Supplementary Fig. 2h),
allowed for the relative protein quantiﬁcation of more than
4,000 proteins (Supplementary Data 1: XPro). Neurosphere
protein proﬁles at d2 (WT, EGFL7 / ) and d5 (EGFL7 / )
were comparable (Supplementary Fig. 2i) and indicative of
enhanced metabolism and proliferation. Comparison of log2 ratio
distributions of EGFL7 / and WT at d2 and d5 by a Violin
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plot (Supplementary Fig. 2j) revealed a wider distribution
of proteins at d5, indicating distinct molecular signatures of
EGFL7 / and WT spheres. Differential protein expression
using gene ontology (GO) annotations and one-dimensional
enrichment displayed 317 distinct GO categories at a false
discovery rate (FDR) below 0.01 (Supplementary Data 2: XGO)
and revealed a lack of synaptic proteins in EGFL7 / spheres at
d5 (Fig. 2d, Supplementary Fig. 2k). Moreover, proteins afﬁliated
with glutamate receptors, potassium channels, synaptic vesicles
and juxtaparanode regions of axons were two- to ﬁve-fold
downregulated, suggesting EGFL7 / retained maturation of
neurosphere cells and kept aNSCs in a proliferative mode.
Limited differentiation paralleled by retained proliferation of
EGFL7 / spheres was further analysed by a cell cycle analysis,
which revealed an increased amount of cells in G2/M phase at the
expense of cells in G0/G1 phase (Fig. 2e). An increased amount of
neurospheres was recovered from the aNSC and TAP populations
upon FACS-puriﬁcation of SVZ-cells (Fig. 2f indicating that in
particular the sphere formation capacity of aNSCs was increased
in EGFL7 / mice.
Continuous live imaging of primary EGFL7 / and
WT cultures was performed to track proliferation and lineage
progression of NSCs/NPCs in vitro (Fig. 2g–r) in the absence
of growth factors. Time-lapse video microscopy of primary
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Figure 1 | Localization of EGFL7 expression in the mouse brain and SVZ. (a) Two expression maxima of EGFL7 were detected at E9 and E15/E18 by
qRT-PCR. EC, endothelial cells, positive control; NS, neurospheres, low level reference. (b) In situ hybridization of EGFL7, E9 mouse embryo. (c) Higher
magniﬁcation of the inset in (b). EGFL7 was expressed in ECs (arrowheads). (d) Negative control of (b). (e) Continuous EGFL7 expression measured in the
mouse brain by qRT-PCR until high age with a maximum at P40. (f) In situ hybridization of EGFL7, P40 cortex. (g) Higher magniﬁcation of the inset in (f).
EGFL7 was expressed in ECs (arrowheads) and non-ECs (asterisks). (h) Negative control of (f). (i–l) The following markers were applied to discriminate
among different cell types by FISH and IF analysis: CD31 for endothelial cells (ECs), Nestin and GFAP for aNSCs or GFAP for astrocytes. (j,l) Higher
magniﬁcation of the inset in (i,k) EGFL7 expression was majorly detected in ECs (j, arrowheads) and aNSCs/NPCs (l, arrowheads). Astrocytes stained
negative for EGFL7 (l, arrow). (m) SVZ cell populations were FACS-puriﬁed using the following combinations of markers for discrimination: CD31þ for ECs,
GLASTþ/CD133þ/EGFR for qNSCs, GLASTþ/CD133þ/EGFRþ for aNSCs, CD133/EGFRþ for TAPs, CD24þ for NBs, CD24þ/CD133þ for Eps and
GLASTþ/CD133 for astrocytes. qRT-PCR revealed high EGFL7 expression in qNSCs and ECs, moderate expression in aNSCs and TAPs but no expression
in NBs, Eps and astrocytes (ND). LV, lateral ventricle. Scale bar, 500mm (f), 200mm (h), 100mm (b,g), 50mm (d), 25mm (c,i,k) and 5mm (j,l).
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NSC/NPC cultures was performed by a cell observer for 5–7 d.
Under these culture conditions, aNSCs exhibited a prototypical
lineage tree (Supplementary Movie 1) and recapitulated
NSC differentiation in vitro26. Subsequent to acquiring the
characteristic morphology of quiescent astroglial cells, EGFL7 /
NSCs re-entered the cell cycle (Fig. 2k–m and Supplementary
Movie 2) and re-started differentiation, an effect never observed
before with WT cells. Data suggest loss of EGFL7 increased the
amount of proliferating aNSCs/NPCs by the reactivation of
quiescent cells.
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EGFL7 modiﬁed Notch signalling in the SVZ. Previously,
EGFL7 has been identiﬁed as a non-canonical Notch ligand that
affects Notch signalling in vitro. This ﬁnding was veriﬁed by
the infection of neurospheres with AdEGFL7 (an adenovirus
encoding for EGFL7), which caused a reduction in the relative
amount of the Notch reporter gene Hes5 (Fig. 3a) as previously
presented22. However, cerebroventricular injection (CVI) of
AdEGFL7 to induce expression of EGFL7 in the SVZ, followed
by microdissection of the SVZ, RNA isolation and qRT-PCR,
revealed elevated levels of Hes5 upon ectopic EGFL7 expression
(Fig. 3b). Conversely, Hes5 levels were elevated in EGFL7 /
neurospheres (Fig. 3c) and total Hes5 levels were decreased in the
SVZ of EGFL7 / mice (Fig. 3d). Two-coloured multiplex FISH
in WT SVZ tissue, combining EGFL7 and Hes5 in situ probes,
revealed that Hes5 levels close to cells expressing EGFL7 were
higher as compared to regions without EGFL7 in the SVZ
(Fig. 3e,f). Micrographs were subjected to Imaris-based
quantiﬁcation and cross-correlation analysis. Regions staining
positive for EGFL7 yielded stronger signals for Hes5 as compared
to regions with low EGFL7 levels (Fig. 3f,g).
To deﬁne potential candidates responsible for the differential
effects of EGFL7 in vitro and in vivo, Notch signalling
components in SVZ and neurospheres were quantiﬁed by qRT-
PCR. Prominent levels of the Notch receptors 1–3, the canonical
ligands Jagged1 and Dll1 as well as the Notch reporter genes Hes1
and Hes5 were spotted in both tissues (Supplementary Fig. 3a,b),
but Notch4, Jagged2 and Dll3 were mostly absent. Notch3,
Jagged1, Dll1 and Hes1 displayed markedly increased expression
levels in neurospheres as compared to the SVZ, while Notch2 was
slightly reduced. Interestingly, the Notch ligand Dll4 displayed a
differential expression pattern and was readily detectable in SVZ
tissue but not in neurospheres. In vivo localization of these Notch
signalling components was performed by two-coloured multiplex
FISH, combining an EGFL7 in situ probe with probes for
Notch1–3, Jagged1, Dll1 or Dll4. Data revealed an ubiquitous
expression of Notch1–3 in the SVZ (Fig. 3h,i and Supplementary
Fig. 3c,d) as previously described27. Co-localization with EGFL7
occurred in individual hotspots and often within the same cell.
Expression of the Notch ligands Jagged1, Dll1 and Dll4 was not as
ubiquitous compared to the Notch receptors but displayed a
more punctuated pattern with individual hotspots colocalizing
with EGFL7, usually in neighbouring cells (Fig. 3j,k
and Supplementary Fig. 3e,f). Interestingly, IF staining of
Dll4 revealed its prominent expression in blood vessels
(Supplementary Fig. 3g), where it readily colocalized with
EGFL7 (Supplementary Fig. 3h).
To investigate the inﬂuence of ectopically expressed Dll4
in vivo, CVI of adenovirus encoding for Dll4 (AdDll4) into the
ventricle of WT mice was performed. IF and quantiﬁcation of
aNSCs and their progeny revealed a decreased amount of
proliferating aNSCs/NPCs (Fig. 3l) and TAPs (Fig. 3m) in the
SVZ of AdDll4-infected animals. Conversely, the induced blood
vessel-speciﬁc knockout of Dll4 in Dll4iDEC mice, created by
treatment of Dll4ﬂ/ﬂ;Cdh5(PAC)-CreERT2 animals with tamox-
ifen, increased the amount of proliferating aNSCs/NPCs (Fig. 3n)
and TAPs (Fig. 3o). The amount of primary neurospheres,
forming from microdissected SVZ tissue of these animals ex vivo,
was increased upon Dll4 knockout in blood vessels (Fig. 3p).
Remarkably, the stem cell-speciﬁc knockout of Dll4 using a
Dll4ﬂ/ﬂ;Nestin-CreERT2 model (Dll4iDNSC) did not affect primary
sphere formation (Supplementary Fig. 3i), suggesting negligible
autocrine Dll4-mediated Notch signalling within the NSC
population. The amount of these neurosphere initiating cell-
derived spheres (NICs) ex vivo served as a measure for the
amount of aNSCs in vivo. Injection of AdEGFL7 into the ventricle
of Dll4ﬂ/ﬂ;Cdh5(PAC)-CreERT2 animals reduced the amount of
NICs by about 40% (Fig. 3p) but this phenotype was reduced
upon Dll4 knockout in blood vessels (ca.  25%). Conversely,
injection of AdDll4 into the ventricle of EGFL7 / mice
(Fig. 3q) reduced the amount of NICs (ca.  25%), however, to a
lesser extent as compared to WT controls (ca.  35%). Data
suggest endothelial Dll4 and EGFL7 act as cooperative regulators
of NSC activity.
Indeed, Dll4 and EGFL7 induced Notch signalling in a
cooperative manner as measured by qRT-PCR of the Notch
target gene Hes5 in neurospheres seeded on plastic dishes coated
with recombinant puriﬁed proteins (Supplementary Fig. 3j).
Furthermore, knockdown of Dll4 or EGFL7 in human umbilical
vein endothelial cells (HUVECs) using speciﬁc siRNAs reduced
the amount of Notch signalling in the co-cultured murine NSCs
in an additive manner as measured by qRT-PCR of murine Hes5
(Supplementary Fig. 3k). To determine the molecular mechanism
behind these observations, the interactions of Notch1 with its
ligands EGFL7, Dll4 and Jagged1 were studied. Flag-tagged
EGFL7 and the V5-tagged extracellular domains of all four
Notch receptors were co-expressed in HEK293 cells. Subsequent
co-immunoprecipitation (co-IP) analyses followed by quantita-
tive western blot using an Odyssey system revealed that EGFL7
bound strongest to the ECD of Notch1 but with declining
strength to Notch2 (ca. 76%), Notch3 (ca. 41%) and Notch4
(ca. 35%) (Supplementary Fig. 3l; n¼ 3; Po0.05). Subsequently,
the EGFL7 binding site within Notch1 was mapped using
Flag-tagged EGFL7 along with V5-tagged Notch1-ECD deletion
mutants. These constructs lacked different EGF-like repeats that
are relevant for Notch signalling. Co-IPs revealed reduced
binding of EGFL7 to Notch1 mutants lacking EGF-like
repeats relevant for Notch1 activation in trans (paracrine)
(Supplementary Fig. 3m; Notch1-D5–10 (ca.  18%), Notch1-
Figure 2 | EGFL7 affected SVZ-derived neurospheres. (a) Scheme of neurosphere assay. (b) Ectopic EGFL7 expression increased the amount of small
neurospheres (19.7±3.31 versus 1.54±1.34% in AdMock; n¼ 100; Po0.01), while (c) EGFL7 / spheres displayed an increased size (35.3±2.98 versus
20.15±5.23% in WT; n¼ 100; Po0.01). (d) SILAC-based mass spectrometric proteome analyses of EGFL7 / and WT neurospheres was performed
after 2 and 5 d in culture. WT spheres upregulated proteins involved in neuronal signalling, for example, glutamate receptors or synaptic proteins at d5,
suggesting differentiation in vitro. However, EGFL7 / spheres displayed limited upregulation of these proteins but instead, retained an expression proﬁle
at d5 that was comparable to WT and knockout (KO) spheres at d2 in culture with high levels of riboproteins and metabolic enzymes. This indicates that
EGFL7 / spheres displayed delayed differentiation but sustained proliferation in vitro resulting in larger spheres. (e) Cell cycle analysis revealed an
increased amount of cells in the G2/M phase (9.08±0.62 versus 6.91±0.61% in WT; n¼ 3; Po0.05) at the expense of cells in G0/G1 phase
(65.36±2.40 versus 69.76±0.80% in WT; n¼ 3; Po0.05). (f) FACS sorting of qNSCs, aNSCs, TAPs and NBs from the SVZ of EGFL7 / and WTmice
was performed using the following markers: qNSCs (GLASTþ/CD133þ/EGFR ), aNSCs (GLASTþ/CD133þ/EGFRþ ), TAPs (CD133/EGFRþ ) and
NBs (CD24þ ). Subsequently, an in vitro neurosphere formation assay yielded an increased amount of spheres derived from the aNSC population
(32.3±5.1 versus 21.7±3.7% in WT; n¼ 3; Po0.05). (g–r) Time-lapse video microscopy analysis of primary NSC/NPC cultures. (g–p) Individual time
points of the experiment. (q) Post hoc cell identiﬁcation by IF. Scale bar, 50mm. (r) A typical differentiation tree of EGFL7 / aNSCs displays initial cell
divisions (red arrows) and differentiation but subsequently, re-entering of cell cycle (yellow arrows) and further differentiation, which is not observed in
WT. Statistical analysis was performed by Student’s t-test/Mann–Whitney U-test. For all experiments data, error bars indicate s.d.
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Figure 3 | EGFL7 modiﬁed Notch signalling in the SVZ. (a) Ectopic EGFL7 reduced Hes5 in neurospheres in vitro22 (0.23±0.01 versus 1±0.02-fold in
AdMock; n¼ 3; Po0.001) (b) but increased it in SVZ tissue in vivo (1.97±0.25 versus 1±0.33-fold in AdMock; n¼ 3; Po0.05). (c) Conversely, Hes5 was
upregulated in EGFL7 / spheres (1.96±0.04 versus 1±0.03-fold in WT; n¼ 3; Po0.01) but (d) downregulated in the SVZ of EGFL7 / mice
(0.52±0.05 versus 1±0.18-fold in WT; n¼ 3; Po0.005). (e,f) FISH revealed co-localization of Hes5 and EGFL7 mRNAs in the SVZ (arrowheads),
(g) quantiﬁed by cross-correlation analysis (r¼0.46; Po0.005). (h–k) EGFL7 and Notch1 transcripts were spotted in close vicinity or within the same cell
(h,i, arrowheads) while EGFL7 and Dll4 were found exclusively in neighbouring cells (j,k, arrowheads). (f,i,k) Higher magniﬁcations. LV, lateral ventricle.
Scale bar, 25 mm (e,h,j) or 5 mm (f,i,k). (l) Ectopic Dll4 in vivo reduced aNSCs (17.79±1.08 versus 35.29±6.99 cells per mm in AdMock; n¼ 3; Po0.05)
and (m) TAPs (15.22±2.52 versus 24.18±2.01 cells per mm in AdMock; n¼ 3; Po0.05). Conversely, Dll4-deﬁcient blood vessels increased (n) aNSCs
(45.33±4.12 versus 22.95±4.66 cells per mm in WT; n¼ 3; Po0.05) and (o) TAPs (39.11±3.41 versus 28.80±3.99 cells per mm in WT; n¼ 3; Po0.05)
in the SVZ. Dll4iDEC mice (p) gave rise to more primary neurospheres ex vivo (NICs; 503.67±21.55 versus 452.5X±7.78 spheres in WT; n¼ 3; Po0.05),
an effect partially reversible by AdEGFL7. (q) EGFL7 / yielded more NICs ex vivo but AdDll4 could not fully rescue this phenotype. (r) Biochemical
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using Student’s t-test/Mann–Whitney U-test. Error bars indicate s.d.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15922
6 NATURE COMMUNICATIONS | 8:15922 | DOI: 10.1038/ncomms15922 | www.nature.com/naturecommunications
D11þ 12 (ca.  26%) and Notch1-D8 (ca.  28%); n¼ 3;
Po0.05). Remarkably, Notch1-D24–29, lacking a region
responsible for in cis (autocrine) inactivation of Notch1, was
not signiﬁcantly impaired in EGFL7 binding. This indicates that
EGFL7 may interfere with Notch activation in trans without
affecting inactivation in cis. Furthermore, the consequences of
EGFL7 expression for the binding of Notch1 to its ligands
Jagged1 and Dll4 were studied. V5-tagged Notch1-ECD and
Flag-tagged ligands were co-expressed in HEK293 in the absence
or presence of EGFL7. Co-IPs revealed that EGFL7 reduced
Notch1 binding to Jagged1 (ca.  92%) but increased binding to
Dll4 (ca. þ 37%) (Fig. 3r, Supplementary Fig. 3n). Thereby
EGFL7 promoted Notch1 activation induced by Dll4 at the
expense of Jagged1.
EGFL7 modulated the cytoarchitecture of the SVZ. To quantify
the impact of EGFL7 on adult neurogenesis in the SVZ in vivo,
aNSCs and their progeny were quantiﬁed by IF (Fig. 4a). Mice
underwent CVI of AdEGFL7 to ectopically express EGFL7 in the
SVZ, AdMock served as a negative control (Fig. 4b). Effective
infection in vivo was veriﬁed by the detection of virus-encoded
EGFP and anti-EGFL7 IF staining (Supplementary Fig. 4a–e).
AdEGFL7 did neither affect the total number of aNSCs/NPCs
(Supplementary Fig. 4f) nor apoptosis as detected by TUNEL
staining (Supplementary Fig. 4g–i). IF of the proliferation marker
Ki67 revealed a decreased amount of proliferating aNSCs/NPCs
in vivo on CVI of AdEGFL7 (Fig. 4c–e). Further, AdEGFL7
caused an increase in the amount of TAPs (Fig. 4f–h) and NBs
(Fig. 4i–k). IF analysis of EGFL7 / and WT tissue (Fig. 4l)
yielded a comparable amount of aNSCs/NPCs (Supplementary
Fig. 4j) but an increased amount of proliferating aNSCs/NPCs in
EGFL7 / mice (Fig. 4m–o). However, the amount of TAPs
(Fig. 4p–r) and NBs (Fig. 4s–u) was reduced. The conditional
EGFL7 knockout model EGFL7ﬂ/ﬂ;Nestin-CreERT2 (EGFL7iDNSC)
phenocopied these observations and displayed a reduced amount
of TAPs (Supplementary Fig. 4k) and NBs (Supplementary
Fig. 4l), indicating that this effect was speciﬁc for adult NSCs.
Data suggest ectopic expression of EGFL7 in the SVZ pushed
aNSCs towards neuronal differentiation while the loss of EGFL7
delayed this process and caused an accumulation of proliferating
aNSCs in vivo.
EGFL7 changed the activation state of NSCs. Initially, the
amount of aNSCs in vivo was assessed by counting NICs; less
spheres were recovered from AdEGFL7-infected SVZ tissue
(Fig. 5a). Further, proliferating cells in the SVZ were labelled by
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injection of the base analog BrdU. The number of label-retaining
cells (LRCs) in the SVZ was counted 4 weeks later as a measure
for actively proliferating cells that had returned to quiescence.
A reduced number of LRCs formed in the SVZ of AdEGFL7-
infected mice (Fig. 5b).
Subsequently, the time course of cellular reconstitution of the
SVZ on removal of all proliferating cells was assessed. To achieve
this, the anti-mitotic drug AraC was infused into the lateral
ventricle for 1 week using osmotic pumps and paralleled by CVI
of AdEGFL7 or AdMock. Subsequently, BrdU was administered
for 3 d to label the proliferating cells replenishing the stem-cell
niche. The cytoarchitecture of the SVZ was analysed 10 d after
disposal of AraC by IF (Supplementary Fig. 5a). AraC led
to depletion of the SVZ from all proliferating cells, including
aNSCs/NPCs, TAPs and NBs but did not affect slowly
dividing cells such as qNSCs (Supplementary Fig. 5b,c). The
total amount of aNSCs/NPCs was not signiﬁcantly altered
(Fig. 5c) but lower numbers of proliferating aNSCs/NPCs were
counted in AdEGFL7-infected mice (Fig. 5d). This caused a
decrease in newborn TAPs (Supplementary Fig. 5d), NBs
(Supplementary Fig. 5e) and proliferating cells in total
(Supplementary Fig. 5f). In conclusion, expression of EGFL7
delayed the repopulation of the NSC niche in the SVZ upon AraC
treatment, indicating that ectopic EGFL7 pushed aNSCs towards
quiescence.
Further, more NICs were recovered from the SVZ of EGFL7 /
mice (Fig. 5e) and the amount of LRCs in EGFL7 / mice was
decreased (Fig. 5f), indicating that less aNSCs returned to
quiescence and/or were reactivated more rapidly. Application of
AraC to EGFL7 / mice, which harbour an increased aNSC
pool, reduced the absolute amount of aNSCs/NPCs by about 50%
(Fig. 5g). Consequently, a delayed repopulation of the SVZ with
aNSCs/NPCs (Fig. 5h), TAPs (Supplementary Fig. 5g), NBs
(Supplementary Fig. 5h) and proliferating cells (Supplementary
Fig. 5i) was observed. Data indicate that the loss of EGFL7 caused
an increase in aNSCs at the expense of qNSCs, which was
quantiﬁed by FACS analysis2. A higher proportion of aNSCs was
retrieved from the SVZ of EGFL7 / mice (Fig. 5i,j), verifying
that the loss of EGFL7 caused a shift from qNSCs into aNSCs.
IF analysis of SVZ tissue by the marker combination GFAPþ /
Nestin /S100b 2 revealed an increased amount of qNSCs upon
CVI of AdEGFL7 (Fig. 5k,l) but a decrease in EGFL7 / qNSCs
(Fig. 5m,n). The amount of differentiated GFAPþ /Nestin /
S100bþ astrocytes, however, was not signiﬁcantly altered upon
AdEGFL7 CVI or in EGFL7 / animals (Supplementary
Fig. 5j,k). Subsequently, we compared the amount of qNSCs
in mice speciﬁcally lacking EGFL7 in aNSCs (EGFL7ﬂ/ﬂ;
Nestin-CreERT2) or blood vessels (EGFL7ﬂ/ﬂ;Cdh5-CreERT2).
While the former mice remained unaffected (Fig. 5o,p), the latter
displayed a signiﬁcant decrease in qNSCs (Fig. 5q,r). Data suggest
that vascular rather than neural EGFL7 affected the activation
state of NSCs in the SVZ.
EGFL7 altered neurogenesis and behaviour. The inﬂuence of
EGFL7 on NSCs/NPCs suggested an effect on neurogenesis,
therefore the amount of adult-born neurons in the OB was
determined. Proliferating cells were labelled with BrdU (Fig. 6a)
and 28 d later more adult-born neurons were counted in the OB
of AdEGFL7-infected mice (Fig. 6b–d). Conversely, a reduced
number of newborn cells was detected in the OB of EGFL7 /
(Fig. 6e–g) or tamoxifen-induced adult EGFL7ﬂ/ﬂ;Nestin-
CreERT2-knockout mice (Fig. 6h). However, the absolute sizes of
the brains, ventricles, OBs and OB substructures, measured by
magnet resonance imaging, were not changed in EGFL7 /
mice (Supplementary Fig. 6a).
Consequences for neuronal processing were analysed using
extracellular electrophysiological recordings in the dorsal mitral
cell layer of the mid-anterior OB (Supplementary Fig. 6b–h).
Interestingly, the ﬁring rate of mitral neurons in EGFL7 / mice
in response to the olfactory stimulant amyl acetate was increased
(Fig. 6i). Cross-correlation analysis of simultaneously recorded
neurons in EGFL7 / and WT mice revealed a majority of
synchronous interactions in WT as opposed to majorly
asynchronous interactions in EGFL7 / mice (Fig. 6j).
Together, data suggest that the feedback inhibition accounting
for the synchrony of mitral cells was affected in EGFL7 / mice,
resulting in an increased ﬁring rate and diminished synchrony of
coﬁring neurons upon olfactory stimulation.
To determine whether this abnormal neuronal transmission in
the OB affected olfactory sensing, behavioural assays were
performed in EGFL7 / mice. Animals were not impaired in
their general activity, motor balance, sensorimotor gating, social
behaviour, anxiety or pain (Supplementary Fig. 6i–n). However,
EGFL7 / mice displayed abnormalities in olfactory habitua-
tion/dishabituation tests. EGFL7 / and WT mice displayed
comparable exploration and habituation of the neutral scent
water but WT mice displayed increased exploration of the scent
vanilla, while EGFL7 / did not (Fig. 6k). The same counts
using urine of an unfamiliar male (Fig. 6l). Further, olfactory tests
based on the innate mouse avoidance of particular scents were
performed. Increasing concentrations of 2-methylbutyric acid
(2-MB), a component of spoiled food, were presented in different
concentrations to the animals. Comparing the exploration time
of increasing 2-MB dilutions with water revealed increasing
avoidance of this scent by WT but not EGFL7 / animals
(Fig. 6m). Even more striking was a test using trimethylthiazoline
(TMT), a constituent of fox urine. Essentially, WT littermates
sensed TMT at each dilution and never explored it like water.
However, EGFL7 / mice reacted to TMT only at very high
concentrations (Fig. 6n). In the absence of any gross anatomical
abnormalities of the olfactory epithelium (Supplementary
Fig. 6o–q) or behavioural peculiarities of EGFL7 / mice it
can be concluded that these animals were impaired in their ability
to sense odours.
Discussion
The NSC niche in the SVZ maintains radial glia-derived NSCs
which undergo a fascinating metamorphism upon activation,
which eventually allows them to become functional neurons in
the OB1. NSCs remain in an undifferentiated, quiescent state and
need to enter the cell cycle before being able to differentiate into
neuronal progenitors and mature neurons. Many of these
processes take place in the close proximity of blood vessels
within a specialized vascular niche and are indeed regulated by
blood vessel-derived proteins4,9,10. However, only a few of these
vascular factors have been described. In the current work,
the potential of EGFL7 to act as a factor shaping the
microenvironment in the vascular niche to regulate NSCs and
neurogenesis in the SVZ was analysed.
Previously, EGFL7 has been described to govern blood vessels
(reviewed by Nikolic et al.28) and as a regulator of NSCs
in vitro22. Our developmental studies identiﬁed two waves of
EGFL7 expression in the murine embryo. One around E9 when
much of the vascular network is formed and when EGFL7
expression was restricted to ECs. The other started in neurons
around E18 and reached its maximum at P40. Previous
developmental studies focused on the vascular functions
of EGFL7 and the early expression patterns at E9.5-E13.5,
leaving the late onset expression of EGFL7 in neurons
undiscovered29.
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In the SVZ EGFL7 was readily detectable22, which offered
the possibility that ChATþ neurons, themselves regulating
neurogenesis in the SVZ30, transported EGFL7 there by their
axons. However, expression studies revealed that neurons are
only a minor source of EGFL7 in the SVZ, but ECs and NSCs/
NPCs synthesize the majority of EGFL7. NSCs reside in close
proximity to blood vessels15, putatively, regulated by hypoxia,
which regulates both, EGFL7 expression31 and neurogenesis32.
EGFL7 / neurospheres displayed an increased self-renewal
potential and became larger, which was likely mediated by the
previously reported inhibition of Jagged1-induced Notch1
signalling22. Comparison of the transcriptomes of EGFL7 /
and WT neurospheres revealed that EGFL7 / spheres
experienced a delay in differentiation in vitro. WT spheres
upregulated proteins of neuronal signalling at d5, for example,
glutamate receptors or synaptic proteins, whereas EGFL7 /
spheres retained a protein expression proﬁle similar to d2 and
indicative of increased metabolic activity2. We hypothesize that
delayed differentiation and sustained proliferation of EGFL7 /
aNSCs caused larger neurospheres.
However, the inﬂuence EGFL7 exerted on Notch signalling as
measured by Hes5 levels in neurospheres and SVZ tissue was,
in part, in opposition. A comparable discrepancy has been
described for the canonical Notch ligands Jagged1 and Dll1,
which increased the self-renewal potential of neurospheres
in vitro33,34 but kept NSCs quiescent in vivo18,35. Data obtained
in neurospheres may therefore not directly be transferred to
NSCs in the SVZ. This could be due to the focus of this assay
on aNSCs and their progeny but also due to a lack of a proper
stem-cell niche36. We hypothesized that EGFL7 may exerted its
effect on Hes5 by Notch signalling components differentially
expressed in SVZ tissue and neurospheres. An expression screen
of various Notch signalling components identiﬁed the Notch
ligand Dll4 as a potential niche component that was expressed on
blood vessels but absent from neurospheres.
The canonical Notch ligands Dll4 and Jagged1 interact with
Notch1 in two different ways. Either paracrine in trans, which
activates Notch signalling, or autocrine in cis, which inhibits
Notch37. Molecular interaction analyses displayed preferential
binding of EGFL7 to the region in Notch1 that is responsible for
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Figure 6 | EGFL7 altered neurogenesis and behaviour. (a) Experimental set-up. (b–d) Ectopic EGFL7 increased the amount of adult-born neurons
(IF; 229.8±7.56 versus 176.7±7.14 cells per mm in AdMock; n¼ 6; Po0.005), while (e–g) less neurons were detected in the OB of EGFL7 /
(135.9±21.79 versus 274.6±28.35 cells per mm in WT; n¼ 6; Po0.005) or (h) EGFL7iDNSC mice (242.0±42.37 versus 424.3±18.68 cells per mm in
WT; n¼ 3; Po0.05). (i,j) Electrophysiological conduction from mitral cells in the OB of EGFL7 / mice revealed (i) an increase in the average evoked
ﬁring rate of EGFL7 / mice upon amyl acetate exposure (8.55±1.17 versus 6.41±0.66% in WT; n(WT)¼ 53, n(EGFL7 / )¼43; Po0.05). (j)
Comparison of the proportions of synchronous (black boxes) and asynchronous ﬁring neurons (white boxes) or other interacting neurons (grey boxes)
upon exposure to amyl acetate revealed a majority of asynchronous ﬁring (46±13 versus 26±14% in WT; Po0.05; n(WT)¼ 53, n(EGFL7 / )¼43) in
EGFL7 / mice but synchronous ﬁring in WT (37±15 versus 63±19% in WT; Po0.05; n(WT)¼ 53, n(EGFL7 / )¼43). (k,l) EGFL7 / mice
displayed a deﬁcit in olfactory preference for both (k) artiﬁcial (water/vanilla; 3.53±2.16 versus 6.03±4.23 s in WT; n¼ 12; F(2, 56)¼4.047, Po0.05,
two-way ANOVA for repeated measures) and (l) natural (water/male urine; 6.0±3.42 versus 10.53±7.35 s in WT; n¼ 12; F(2, 50)¼ 5.891, P¼0.005,
two-way ANOVA for repeated measures) scents. (m,n) EGFL7 / mice displayed elevated tolerance to (m) 2-MB (79.49±81.3 versus 20.1±23.73% in
WT; n¼ 20; F(6, 282)¼ 2.319, Po0.05, two-way ANOVA for repeated measures) and (n) TMT (116.36±99.25 versus 56.36±55.13% in WT; n¼ 13;
F(1, 18)¼ 7.351, Po0.05, two-way ANOVA for repeated measures) in olfactory avoidance tests. Data suggest loss of EGFL7 impaired olfactory perception.
Scale bar, 50mm (b,c,e,f).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15922
10 NATURE COMMUNICATIONS | 8:15922 | DOI: 10.1038/ncomms15922 | www.nature.com/naturecommunications
activation in trans (EGF-like repeats 11 and 12) but not the ones
engaged for Notch deactivation in cis (EGF-like repeats 24 to 29).
Therefore it could be concluded that EGFL7 predominantly
affected Notch1 activation in trans. In the neurovascular stem-cell
niche the interaction between Dll4 and Notch1 may only occur
in trans because Dll4 expression is restricted to blood vessels and
is therefore solely activating. Jagged1, however, is ubiquitously
expressed18,20,33 and may either activate or inhibit Notch
signalling in NSCs. Furthermore, EGFL7 competed with
Jagged1 for binding to Notch1, while it cooperated with Dll4,
probably due to the direct binding of EGFL7 and Dll422.
Previously, this ligand has been discussed in the context of
NPCs18,38 but an effect on NSCs has not yet been described.
These observations allowed for the hypothesis that elevated levels
of EGFL7 in the SVZ in vivo inhibited Jagged1 binding to Notch1
in trans but this loss was compensated by the increased
recruitment of Dll4. However, in neurospheres in vitro, Dll4
was not present and no compensation for Jagged1 could occur in
the presence of high levels of EGFL7. Therefore, only the Notch
inhibiting potential of Jagged1 was executed under this condition.
In conclusion, we suggest that the opposing effects EGFL7 exerts
on Notch signalling in vitro and in vivo resulted from a
combination of its preferred binding site in Notch1 and its
differential inﬂuence on Dll4 and Jagged1 binding to Notch1.
Furthermore, we could show that blood vessel-derived Dll4
pushed NSCs towards quiescence in vivo. Assuming EGFL7
affected NSCs in part by vascular Dll4, it was to be expected that
EGFL7 pushes aNSCs towards quiescence as well. Conversely,
an accumulation of proliferating aNSCs in EGFL7 / mice was
expected in vivo.
Indeed, ectopic expression of EGFL7 pushed aNSCs towards
differentiation into TAPs, NBs and eventually interneurons. This
was probably due to the transient inhibition of Jagged1-mediated
Notch signalling in aNSCs and therefore comparable to the
situation in RBPJ / mice19, where the induced knockout of this
central Notch signalling component led to a transient activation
of neurogenesis in the adult SVZ. Conversely, loss of EGFL7
caused an accumulation of aNSCs within the SVZ and a smaller
proportion of them entered the neuronal differentiation pathway.
Consequently, less interneurons were formed in the OB of adult
EGFL7 / mice. This indicates that EGFL7 is necessary for
neuronal differentiation of NSCs but also affects their activity
state. Quantitative comparison of both pools in the SVZ
by FACS2,39,40 revealed that EGFL7 / mice harboured an
enlarged pool of aNSCs, which was veriﬁed by primary explant
assays (NICs)2,41.
AraC-mediated depletion of mitotic cells in the SVZ of
EGFL7 / mice reduced the total amount of aNSCs, indicating
that a larger proportion of aNSCs were in an activated mitotic
state at the time of the experiment as compared to WT. This
effect was also reﬂected in the amount of LRCs in the SVZ.
Actively proliferating cells were labelled with BrdU. Subsequently,
cells either departed towards the OB or returned to quiescence to
form LRCs, which were markedly reduced in EGFL7 / mice
after 1 month. However, two scenarios are possible and either less
aNSCs returned to quiescence in the ﬁrst place or the ones that
did were reactivated more rapidly. In both scenarios EGFL7 was
needed to keep NSCs quiescent. Live microscopy on NSCs
in vitro42 revealed that EGFL7 / aNSCs differentiated but after
a period of rest, re-entered cell cycle. Apparently, EGFL7 is
needed to keep NSCs quiescent.
To deﬁne whether or not the regulation of NSCs/NPCs by
EGFL7 is of physiological relevance for the adult brain, the
amount of adult-born neurons in the OB was determined and was
found to be reduced in EGFL7 / but increased in AdEGFL7-
infected mice. Mitral and tufted cells, the two main excitatory
neural cells in the OB, form embryonically43, while the majority
of interneurons is generated postnatally44 and was found altered
by EGFL7. This life-long modiﬁcation of the local circuit in the
OB with interneurons alters olfactory information processing
and is the basis for olfactory learning45,46. Neuronal conductance
of mitral cells in the OB of EGFL7 / mice showed a higher
signal departing towards the telencephalon, which was due to a
reduction in the amount of inhibitory neurons. However, the loss
of inhibitory interneurons occurred at the expense of
synchronization of mitral cell activity47. This increased the
threshold for odorant detection in olfactory behaviours and
reduced olfactory discrimination, which is in agreement with
previous studies on the impact of mitral cell activity on mouse
behaviour and the role of adult-born neurons in this context48.
Collectively, this work identiﬁes EGFL7 as a neurovascular
regulator of NSCs, governing olfactory perception and behaviour.
On the molecular level, EGFL7 supported vascular Dll4 in
pushing aNSCs towards quiescence but inhibited neural Jagged1
to prevent an excessive expansion of the activated stem cell pool.
Future work will reveal whether the downregulation of EGFL7
and similar factors may be applied to reconstitute or at least
increase the aNSC pool in aged animals to delay the cognitive
decline happening during aging.
Methods
Mouse models. Constitutive EGFL7 / mice were generated and kindly
provided by Weilan Ye, Genentech49. The knockout was achieved by insertion of a
retroviral gene trap vector upstream of intron 2 of the egﬂ7 gene. The insertion
leads to silencing of endogenous Egﬂ7 transcription, and transcripts initiated from
the inserted vector contain stop codons in all three frames, thus abolishing EGFL7
protein synthesis. Conditional EGFL7ﬂ/ﬂ mice were created by insertion of one loxP
cassette upstream of exon 3 and a second one downstream of exon 7, to remove all
putative start codons from the egﬂ7 gene upon Cre-mediated recombination
(ingenious targeting laboratory, Ronkonkoma, USA). Dll4ﬂ/ﬂ mice were provided
by Rui Benedito (CICD, Madrid, Spain), Cdh5(PAC)-CreERT2 mice originated
from Ralf Adams’ lab (Max Planck Institute for Molecular Biomedicine, Mu¨nster,
Germany). Nestin-CreERT2 mice were provided by Beat Lutz (Institute of
Physiological Chemistry, Mainz, Germany) and originated from Gu¨nther Schu¨tz’s
lab (DKFZ, Heidelberg, Germany)50. In general, mice were in a C57BL/6J
background and have been back-crossed for at least six generations.
Two-month-old male Dll4ﬂ/ﬂ;Cdh5(PAC)-CreERT2, Dll4ﬂ/ﬂ;Nestin-CreERT2 or
EGFL7ﬂ/ﬂ;Nestin-CreERT2 mice (n¼ 6 each) received repetitive daily injections of
tamoxifen in peanut oil/ethanol (9:1) as a vehicle at a dose of 0.15mg kg–1 body
weight for ﬁve consecutive days to create adult Dll4iDEC mice, lacking Dll4 in blood
vessels or Dll4iDNSC and EGFL7iDNSC mice, lacking the respective protein in stem
cells and their progeny. Animals equally treated with vehicle only served as
negative controls. Animal experiments were approved by the ethics committee of
the Landesuntersuchungsamt Rheinland-Pfalz, and were performed according to
German Federal Law y8 Abs. 1 TierSchG.
Cerebroventricular injections. Two-month-old male C57BL/6J mice (n¼ 20)
were anaesthetised by intraperitoneal (i.p.) administration of ketamine (100mg kg–
1 body weight) and xylazine (16mg kg–1 body weight) in 0.9% sodium chloride
(NaCl) solution. To avoid hypothermia, mice were kept on an electric blanket
during the entire duration of surgery. In addition, ointment (Bepanthen, Bayer,
Leverkusen, Germany) was applied on the eyes to prevent their dehydration. While
the animals were under deep anaesthesia, a 0.5 cm longitudinal incision was made
with a scalpel above the position of the bregma, which was subsequently visualized
by cleaning the calvarium with 30% H2O2 solution. Mice were ﬁxed in a stereotaxic
frame (Kopf Instruments, Tujunga, CA, USA) and 5 ml of either EGFL7 expressing
or control adenovirus (5 106 particles per ml) were injected during 2min at the
site 0.7mm lateral and 2mm ventral to the dura. The needle was slowly removed
after 2min delay for ventricular pressure equalization. Subsequent to clipping
the cut, the wound was treated with xylocain to locally anaesthetise this area for
several hours. For long-term experiments, mice received BrdU injection for 3 d
starting from post-operative day 1. At the post-operative d 4 (short-term) or 28
(long-term), mice were killed by transcranial perfusion with 4% paraformaldehyde
in PBS. Brains were removed, ﬁxed in 4% paraformaldehyde in PBS at 4 C for 24 h
and subsequently transferred into 30% sucrose in PBS for cryo-protection.
Brains were embedded in Tissue-Tek O.C.T. (Sakura Fintek, Torrance, CA, USA)
compound, frozen on dry-ice and stored at  80 C until further processing.
Coronal cryosections were prepared at a thickness of 10 mm and stored at  20 C.
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AraC treatment. Brain infusion kits combined with Mini-osmotic pumps (2001,
Alzet, Cupertino, CA, USA) were ﬁlled with 2% AraC (Sigma, St Louis, MI, USA)
and implanted on the surface of the brain as described1,8,10. Pumps were implanted
either subsequent to virus injection in the case of EGFL7 gain-of-function
experiments or without prior injection in the case of EGFL7 loss-of-function
experiments using identical stereotactic coordinates. Six days after AraC-infusion,
mice received BrdU injections for 3 d. Mice were killed after 10 d of regeneration
by transcardial perfusion.
Electrophysiology. Extracellular recordings were carried out on three WT and
three EGFL7 / mice 3–5 months in age. Mice were deeply anaesthetised with i.p.
injection of a mixture of ketamine (stock 100mgml–1 Ketanarkon, Streuli Pharma
AG, Uznach, Switzerland) and xylazine (stock 20mgml–1 Xylazine, Streuli Pharma
AG, Uznach, Switzerland) at a ﬁnal concentration of 100mg kg–1 and 10mg kg–1 in
sterile saline solution (NaCl 0.9%, Braun Medical SA, Sempach, Switzerland),
respectively. The withdrawal reﬂex was checked every 30min to monitor
anaesthesia. Body temperature was maintained at 37.5 C using a heating pad
connected to a temperature sensor placed intrarectally (Lis-Medical, Frankfurt,
Germany). The mouse was mounted into a stereotaxic frame for surgery. The
surface of the skull above the OB was cleaned and an incision was made to open a
small window on top of the OB. Single glass coated, platinum- and gold-plated
electrodes with low impedance (1–2MO) were used for extracellular recordings51.
The electrodes were advanced at a 45 angle from the right side into the dorsal OB
to reach the mitral cell layer using a micromanipulator (Kopf Instruments) at the
coordinates: AP¼ þ 4.05 to 4.95mm from bregma, ML¼ 1.2–1.5mm and
DV¼ 200–600 mm. After the ﬁrst penetration the surface of the OB was protected
using 3% pure agarose gel (Carl Roth, Karlsruhe, Germany). An average of seven
electrode penetrations was performed in the mid-anterior OB per animal. The
signal from the electrode was ampliﬁed and ﬁltered (400–2,000Hz), visualized on
an oscilloscope, and conveyed to an ampliﬁer Power 1401 (Cambridge Electronic
Design Limited, Cambridge, UK). The signal was digitized (10,000Hz sampling
rate) using Spike 2 (Cambridge Electronic Design Limited, Cambridge, UK). The
signals were recorded for B1.5min of spontaneous activity followed by 1 s of
odour stimulation and 30 s of evoked activity. Concentration of 4.4 mM of an amyl
acetate dilution was presented to the animal using an olfactometer52. The 1 s odour
exposure was recorded as a triggered signal. Following the recording session
electrolytic lesions were induced at speciﬁc depths using 3 pulses of 5mA for 7 s at
an interval of 5 s. The recorded waveforms were analysed post hoc from electrode
penetration sites in the mitral cell layer only. Spike units corresponding to one cell
were sorted from each recording using Spike 2 (Cambridge Electronic Design
Limited, Cambridge, UK). Peristimulus time histograms for amyl acetate were
calculated for all sorted spike traces using the Neuroexplorer software (Nex
Technologies, Madison, Alabama, USA). The mean spontaneous (prestim) and
evoked (poststim) ﬁring rate for each cell was obtained from the auto-renewal
density plot using the Neuroexplorer software. Cross-correlation analysis was
performed between each cell pair in the multicellular recordings using the
Neuroexplorer software. Cross-correlograms characterized by a symmetric hump
near lag 0 indicated that the cells ﬁre synchronously. Cross-correlograms with
no hump or asymmetric hump near lag 0 were characterized as non-synchronous.
The distribution between cell pairs ﬁring synchronously and asynchronously, in
presence of amyl acetate in WT and EGFL7 / was analysed by two-way Anova.
Firing rates and cumulative frequencies and correlations of mitral cells were carried
out using non-directional Student’s t-test or Mann–Whitney U-test. The
peristimulus responses were analysed by one-way Anova with two factors.
Olfactory habituation/dishabituation behavioural test. The test was performed
as described53 with minor modiﬁcations using adult littermates. This test consists
of sequential presentations of two different odours: water and vanilla. In another
experimental session, water and urine samples of an unfamiliar male mouse were
used. Each odour (or water) is presented in three consecutive trials of 2min per
trial with 1min intertrial interval. Water solutions of the food odourants were used.
Each mouse was presented with fresh odour sample (1 ml) on ﬁlter paper. Odour
samples were presented such that mice have no opportunity to touch/bite the
sample (that is, enclosed in small perforated Petri dish). Presentations were
performed in the clean standard mouse cage. Before presentations animals were
habituated for 30min in this cage. Cumulative snifﬁng time was manually recorded
during each presentation of odour. Snifﬁng is scored when the animal is orienting
towards the dish with its nose 2 cm or closer to the dish.
Olfactory sensitivity behavioural test. Olfactory sensitivity was behaviourally
evaluated by measuring an innate olfactory avoidance behaviour for presentation of
spoiled foods (2-methylbutyric acid, 2-MB) and predators (trimethylthiazoline,
TMT) scents, based on previously described protocol53. Multiple dilutions
(reported in the ﬁgures) of the scent were tested in an increasing concentration
fashion, that is, initially water, followed by the lowest concentration of the scent.
To minimize a potential confounding effect of multiple testing, a test session was
performed with 24 h intervals. The test cage (20 15 13 cm) was virtually divided
into two equal zones, so mice could move freely between the zones. Animals were
ﬁrst habituated to the cage for 10min, and then a ﬁlter paper with 10 ml of test
odourant was introduced into one of the zones. Time (in s) spent in each zone was
measured by Ethovision video-tracking system (Noldus Inc., Wageningen,
Netherlands) during the 3min test period. Avoidance was calculated in per cent,
taking as 100% the time spent in zone with water sample. Responses to 2-MB and
TMT were measured sequentially (2-MB ﬁrst). A freshly washed and autoclaved
test cage were used for each test session.
Elevated plus maze behavioural test. The animal was placed in the central
platform facing an open arm of the plus maze (made of grey Perspex with a
central 5 5 cm central platform, 2 open arms, 30 5 cm and 2 enclosed arms,
30 5 15 cm, illumination 300 lux). Behaviour was recorded for 5min by an
overhead video camera and a personal computer (PC) equipped with Ethovision
(Noldus Inc.) software to calculate the time each animal spent in open or closed
arms. The proportion of time spent in open arms was used for estimation of open
arm aversion (fear equivalent).
Open ﬁeld behavioural test. Spontaneous activity in open ﬁeld was tested in a
grey Perspex arena (120 cm in diameter, 25 cm high). The animal was placed in the
centre of the open ﬁeld and was allowed to explore it for 7min. The behaviour was
recorded by a PC-linked overhead video camera. Ethovision (Noldus Inc.) software
was used to calculate the distance travelled and the time spent in the central versus
the intermediate and peripheral zones of the open ﬁeld.
Rotarod test. Rotarod is a test for motor function, balance and coordination and
comprises a rotating drum, which is accelerated from 4 to 40 revolutions per min
over the course of 5min. Mice were placed individually on the revolving drum
(Ugo Basile, Comerio, Italy). Once they were balanced, the drum was accelerated.
The time in seconds at which each animal fell from the drum was recorded using a
stop-watch. Each animal received three consecutive trials, the longest time on the
drum was used for analysis.
Social behaviour test. Social behaviour was evaluated in a sociability test as
described54. The social testing apparatus was a rectangular, three-chambered box.
Each chamber was 20 40 22 cm. Dividing walls were made from clear Plexiglas,
with rectangle openings (35 35mm) allowing access into each chamber. The
chambers of the social apparatus were cleaned and fresh paper chip bedding was
added between trials. The test mouse was ﬁrst placed in the middle chamber and
allowed to explore for 5min. The doorways into the two side chambers were
obstructed by plastic boxes during this habituation phase. After the habituation
period, an unfamiliar C57BL/6J male (stranger), that had no prior contact with the
subject mice, was placed in one of the side chambers. The location of stranger in
the left versus right side chamber was systematically alternated between trials. The
stranger mouse was enclosed in a small (60 60 100mm), rectangle wire cage,
which allowed nose contact between the bars, but prevented ﬁghting. A weighted
cup was placed on the top of the cage to prevent climbing by the test mice. The
animals serving as strangers had previously been habituated to placement in the
small cage. Both doors to the side chambers were then unblocked and the subject
was allowed to explore the entire social test box for a 10min session. The amount
of time spent in each chamber was recorded by video-tracking system Ethovision
(Noldus Inc.).
Prepulse inhibition of acoustic startle response test. To measure the startle
reactivity, mice were placed in small metal cages (90 40 40mm) which restrict
major movements and exploratory behaviour. The cages are equipped with a
movable platform ﬂoor attached to a sensor recording vertical movements of
the ﬂoor. The cages are placed in four sound-attenuating isolation cabinets
(Med Associates, St Albans, VT, USA). A startle reﬂex is evoked by acoustic stimuli
delivered from a loudspeaker suspended above the cage and connected to an
acoustic generator. The startle reaction of a mouse to the acoustic stimuli evokes a
movement of the platform. The transient force resulting from this movement of the
platform was recorded on a PC during a recording window of 260ms and stored in
the computer for further evaluation. The recording window is measured from the
onset of the acoustic stimuli. An experimental session consisted of a 2min habi-
tuation to the 65 dB background white noise (continuous throughout the session),
followed by a baseline recording for 1min at background noise. After baseline
recording, six pulse alone trials using the startle stimuli of 120 dB intensity and
40ms duration were applied to decrease inﬂuence of within-session habituation.
These data were not included in the analysis of the prepulse inhibition. For tests of
prepulse inhibition, the 120 dB/40ms startle pulse was applied either alone or
preceded by a prepulse stimulus of 70, 75 or 80 dB intensity and 20ms duration.
An interval of 100ms with background white noise was employed between each
prepulse and pulse stimulus. The trials were presented in a pseudorandom order
with an interval ranging from 8 to 22 s. Amplitude of the startle response
(expressed in arbitrary units) was deﬁned as a difference between the maximum
force detected during a recording window and the force measured immediately
before the stimulus onset. Amplitudes were averaged for each individual animal,
separately for both types of trials (stimulus alone, stimulus preceded by a prepulse).
Prepulse inhibition was calculated as a percentage of the startle response using the
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formula: % prepulse inhibition¼ 100 [(startle amplitude after prepulse pulse
pair)/(startle amplitude after pulse only) 100].
Hot plate test. A standard hot plate (Ugo Basile) was used for the assessment of
nociceptive sensitivity, widely used to measure thermal pain threshold. The plate
was heated to 52 C and the mouse was conﬁned there by Plexiglas cylinder
(diameter 19 cm, height 26 cm). Time (in seconds) to show hind paw response
(licking or shaking) or jumping was noted as the pain threshold.
Magnetic resonance imaging (MRI). Brains of EGFL7 / and control mice
(n¼ 13 each) were ﬁxed in formalin. For the MR examination, brains were
processed in agarose (4%) to prevent movement within the scanner. The samples
were placed in a mouse whole body coil (Bruker, Ettlingen, Germany) of a
dedicated small animal ultra-high ﬁeld MR scanner (ClinScan 7 Tesla, Bruker,
Ettlingen, Germany). Imaging sequences and parameters were chosen as follows:
T2-weighted imaging (slices 72, TR 2,000ms, TE 46ms, averages 2, voxel size
0.059 0.059 0.500mm, acquisition time 6:34 h). During data post-processing,
the volumes of the brains, OB, granular cell layers as well as lateral, third and
fourth ventricles were determined in mm3 using Osirix software and a dedicated
plug-in for segmentation purposes (Chimaera, Erlangen, Germany).
Olfactory epithelium. Quantiﬁcation of the olfactory epithelium within the nasal
cavity of EGFL7 / and WT mice was performed as previously described55.
In brief, serial sections were analysed subsequent to HE-staining and were imaged
using a BX51 microscope (Olympus, Tokyo, Japan) equipped with a Retiga 2000R
CCD camera (Q-Imaging, Surrey, BC, Canada). Quantiﬁcations were performed
using ImageJ software.
Neurosphere assays. Primary neurosphere cultures were prepared from adult
C57BL/6J mice (8–12 weeks old) as previously described56. Mice were killed by
cerebral dislocation. Brains were removed and the forebrain was opened under
sterile conditions to access the SVZ for dissection. The tissue was enzymatically
dissociated by incubation in Leibowitz L-15 medium, containing 0.8mgml–1
Papain and 0.5mM EDTA (dissociation medium, preactivated at 37 C for 30min)
at 37 C for 30min. After centrifugation for 3min at 300 g, the supernatant was
removed, and the tissue was resuspended in ovomucoid inhibitor (Worthington,
Lakewood, CO, USA). Cells were triturated with a ﬁre-polished Pasteur pipette,
collected by centrifugation for 3min at 300 g, resuspended in DMEM/F-12 medium
containing 1mM HEPES, 10mgml–1 penicillin, 10mgml–1 streptomycin, 1B27
supplement and 20 ngml–1 EGF and FGF (Peprotech, Rocky Hill, CT, USA) (NSC
medium) and plated in T75 ﬂasks. Cells were incubated at 37 C and 5% CO2 and
passaged every 5 d by enzymatic dissociation with accutase (PAA, Egelsbach,
Germany) at 37 C for 10min under vigorous shaking.
NSC and progenitor populations were isolated from SVZ tissue by a BD FACS
Aria II device using a 100mm nozzle aperture and the marker combinations
GLASTþ /CD133þ /EGFR (qNSCs), GLASTþ /CD133þ /EGFRþ (aNSCs),
CD133 /EGFRþ (TAPs) or CD24þ (NBs). Cells were FACS sorted into 500ml
NSC medium in 24-well plates at a density of 500 cells per well. Neurospheres
started forming on day 3.
For overexpression analyses, intact neurospheres (5 d in vitro) were
enzymatically dissociated as described above. For each condition, 50,000 cells were
plated in 6-well plates. Cells were treated with adenovirus (50 particles per cell) and
grown for 5–6 d in NSC medium. Primary infected or EGFL7 / spheres were
dissociated, plated at clonal density (1 cell per ml) and grown for another 5–7 d.
Alternatively, self-renewal assays were performed under clonal condition upon
FACS sort (1 cell per well). In brief, neurospheres were dissociated and single cells
were sorted into individual 96-well round-bottom wells (10 plates per condition)
based on size and granularity (using the forward and the side scatter). Cells were
cultured in standard medium supplemented with conditioned medium (ratio 1:1)
and were grown for another 10 d. Subsequently, the number of secondary formed
spheres as well as their diameter was determined using an IX70 microscope
(Olympus, Tokyo, Japan). Statistically signiﬁcant differences between groups were
calculated using Student’s t-test or Mann–Whitney U-test.
Cell cycle analysis was performed using Hoechst 33342 (Sigma-Aldrich)57. SVZ
NSCs were incubated with 10 mgml–1 Hoechst 33342 for 45min at 37 in culture
medium. Hoechst 33342 was excited using ultraviolet laser. Single cells were gated
using width and area parameters. The area parameter histogram was used to
determine the percentage of cells in G1, S and G2M phases. Mann–Whitney U-test
was used for statistical analysis.
Time-lapse NSC/NPC microscopy. Adult SVZ-derived NSCs were isolated and
cultured as described26,58,59. In brief, time-lapse video microscopy and single-cell
tracking of adult NSC/NPC cultures were performed using a cell observer (Zeiss,
Oberkochen, Germany) and a TE-2000 microscope (Nikon, Tokyo, Japan), set at a
constant temperature of 37 oC and 8% CO2. Phase contrast/bright ﬁeld images
were acquired every 5min for 5–7 d using a  20 phase contrast objective
(Zeiss/Nikon), an AxioCam HRm camera (Hamamatsu) and AxioVision
4.7/Metamorph software (Zeiss). For subsequent single-cell tracking a self-written
computer program (TTT)60 was employed. Movies were assembled using Image J
1.42q (National Institute of Health, USA) software and are played at a speed of
1–3 frames per s. Under these culture conditions, WT aNSCs/NPCs exhibited a
prototypical differentiation pattern and yielded a prototypical lineage tree as
usually observed by single-cell tracking26,42,61. Brieﬂy, slowly dividing astroglia
(aNSCs) were characterized by a slow cell cycle, signiﬁcant cell growth before
division and the capacity to give rise to asymmetric lineage trees. Slowly dividing
astroglia gave rise to fast dividing astroglia (activated astroglia) that in turn
generated either TAPs or quiescent astroglial cells. Finally, TAPs gave rise to NBs
after a limited number of divisions (Supplementary Movie 1). Characteristics
described in vitro for aNSCs lineage progression were conﬁrmed by BrdU-chasing
or multicolour based clonal analysis in vivo62,63. Importantly, once the quiescent
astroglial morphology had been acquired, WT cells remained quiescent until the
end of the time-lapse imaging experiment, unless cells were challenged with
mitogen growth factors that induced re-entry into the cell cycle26.
RNA isolation and reverse transcription. Mouse embryos or postnatal brains
were mechanically disrupted using mortar and pestle precooled in liquid nitrogen.
Disruption of NSC and mouse lung endothelial cells (EC) was achieved by using
Trizol Reagent (Invitrogen, Carlsbad, CA, USA) as suggested by the manufacturer.
Disrupted tissues and cells were further homogenized by QIAshredder columns
(Qiagen, Hilden, Germany) and RNA was puriﬁed using RNeasy mini kit (Qiagen)
according to manufacturer’s instructions. Concentration and purity of RNA were
determined using the Bioanalyzer 2000 automated electrophoresis system (Agilent,
Santa Clara, CA, USA). An amount of 1 mg of total RNA per sample was used to
synthesize cDNA using oligo-d(T) primers and avian reverse transcriptase (iScript
cDNA Synthesis Kit, Bio-rad, Hercules, CA, USA) according to manufacturer’s
protocol. Concentration and purity of generated cDNA were determined
photometrically by absorption at 260 and 280 nm wavelengths (Biophotometer,
Eppendorf, Hamburg, Germany).
Quantitative real-time PCR (qRT-PCR). qRT-PCR was performed using SYBR
Green ﬂuorescein mix (Thermo Fisher Scientiﬁc, Waltham, USA). Template cDNA
weighing 130 ng and 1 pmol of gene-speciﬁc primers were used per reaction.
PCR reaction and amplicon detection were performed by the iCycler real-time
PCR system (CFX Connect RT-PCR System, Bio-Rad, Hercules, CA, USA).
Quantiﬁcation of expression was normalized according to the relative levels of
cDNA in the samples based on quantitative analysis of the housekeeping genes
(HKG) glyceraldehyde-3-phosphate dehydrogenase , RNA polymerase II (RNAPII)
and ribosomal protein S13 (Rps13). Values were normalized using the CFX
Manager Optical System Software (Bio-Rad). See Supplementary Table 1 for details
on primer sequences. Statistical analysis was performed using the unpaired,
two-tailed t-test (Student’s t-test) or the Mann–Whitney U-test.
Ligand coating and HUVEC-NSC co-culture assays. Six-well plates were
coated with recombinant IgG (11 mgml–1), Dll4 (1mgml–1) or Dll4 plus EGFL7
(10 mgml–1) at 37 C. Dll4 was purchased from R&D Systems (Minneapolis, MN,
USA); IgG and biological active EGFL7 were puriﬁed using a baculovirus system as
described previously22. After 2 h, plates were washed once with NSC medium and
50,000 3-d-old SVZ-derived neurospheres were seeded in 1ml NSC medium per
well. After 1 h of incubation, cells were collected, lysed, RNA was isolated, quality
checked, reverse transcribed into cDNA and then gene expression analysis was
performed by qRT-PCR as described above.
Primary HUVECs (P3–P5) were seeded in complete EBM medium at 300,000
cells per 60mm dish. After 48 h, cells reached 85% conﬂuency and were transfected
with siRNA using the Gene Trans II reagent (MoBiTec, Go¨ttingen, Germany)
according to the manufacturer’s guidelines. The following siRNAs were purchased
from Dharmacon (Lafayette, CO, USA): Scrambled control siRNA (siScr; GGG
AAG CCA UGA ACA ACU U), human EGFL7-speciﬁc siRNA (siEGFL7; GUG
GAU GAA UGC AGU GCU A) and human Dll4-speciﬁc siRNA (siDll4; CAG
AAU GGC UAC UGC AGC A). In brief, 24 ml Gene Trans II was diluted in 156ml
Optimem (Invitrogen) and 9 ml siRNA solution (20mM) were diluted in 132ml
Diluent B. Both solutions were incubated at RT for 5min, combined and incubated
for another 5min at RT. HUVECs were washed twice, covered with 2.7ml
Optimem and the Gene Trans II/siRNA solution was added drop-wise. Cells were
incubated at 37 C and 5% CO2 for 4 h. Subsequently, the medium was removed,
cells were washed once with PBS and 3ml fresh, complete EBM medium was
added. Upon another 48 h, HUVEC medium was removed and cells were washed
once with PBS. A quantity of 70,000 3-d-old SVZ-derived neurospheres were added
in complete NSC medium on top of the conﬂuent HUVEC culture. After 1 h of
incubation, cells were collected, lysed, RNA was isolated, quality checked, reverse
transcribed into cDNA and then gene expression analysis was performed by
qRT-PCR as described above. Notch signalling in mouse NSCs was quantiﬁed
normalizing Hes5 expression to RNA Pol II and GAPDH as murine HKG. The
effective knockdown of EGFL7 and Dll4 in the human HUVEC was detected by
qRT-PCR using speciﬁc probes for EGFL7 and Dll4 and HPRT1 and ACTB as
HKG. Each primer pair tested negative for interspecies cross-reactivity.
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In situ hybridization. Mouse embryos or brains were removed and rapidly rinsed
in diethylpyrocarbonate -treated PBS and then ﬁxed in 4% paraformaldehyde-PBS
at RT overnight. Tissues were automatically dehydrated in ethanol using a vacuum
inﬁltration processor (Tissue-Tek VIP 5 Jr., Sakura, Alphen aan den Rijn,
Netherlands) and embedded in parafﬁn wax. Sections of 5 mm were prepared using
a sliding microtome (SM2000R, Leica, Wetzlar, Germany), mounted on micro-
scope slides and dried at 55 C overnight. The staining procedure including further
processing of the sections such as dewaxing and rehydration was automatically
performed by using the Discovery XT System (Roche, Basel, Switzerland).
Hybridization of DIG-labelled riboprobes was carried out at 65 C for 6 h using
50 ng of DIG-labelled riboprobe per slide diluted in 100ml hybridization buffer.
Detection of DIG was performed using an alkaline phosphatase-coupled
anti-digoxigenin antibody (Roche) followed by colour development with the use of
NBT and BCIP (Roche). Subsequently, cell nuclei were stained with hematoxyline.
Slides were mounted with water-soluble mounting medium (Aqua-Poly Mount,
Polysciences, Eppelheim, Germany). In situ hybridization slides were analysed and
photographed using a BX50 microscope (Olympus, Tokyo, Japan) equipped with a
DP72 camera (Olympus).
Fluorescence in situ hybridization. Mice were killed by transcardial perfusion
with 4% paraformaldehyde-PBS. Brains were removed and post-ﬁxed at 4 C
overnight. Brains were dehydrated in 30% sucrose at 4 C for 24 h and embedded in
Tissue-Tek O.C.T. compound (Sakura), frozen on dry-ice and stored at  80 C.
Cryosections of 10mm were prepared (Cryostat CM 1900; Leica, Wetzlar,
Germany), dried for 30min at 37 C and stored at  20 C until further processing.
FISH was performed using QuantiGene ViewRNA ISH Cell Assay (Affymetrix,
Santa Clara, CA, USA). For multiplexing Type-1 and Type-6 probes were
combined. Images were captured using a confocal microscope (SP8, Leica, Wetzlar,
Germany) and quantitative analyses were performed using Imaris 8 (Bitplane,
Zurich, Switzerland). To determine the correlation between the levels of Hes5
transcripts and the levels of EGFL7 transcripts, the SVZ was segmented in deﬁned
areas of 400 mm2 and the number of transcripts per area was counted (represented
as one data point). A Pearson correlation analysis was performed using GraphPad
Prism 6.0.
Immunohistochemistry. Adult mice were killed by cerebral dislocation. Brains
were removed, embedded in Tissue-Tek O.C.T. compound (Sakura), frozen on
dry-ice and stored at  80 C. Cryosections of 10mm were prepared (Cryostat
HM550; Thermo Fisher Scientiﬁc, Walldorf, Germany), dried for 1 h at 37 C and
stored at  20 C until further processing. Subsequent to a PBS wash, sections were
incubated with blocking solution (10% goat serum plus 0.01% Triton X-100) at RT
for 1 h. Slices were preincubated in mouse-on-mouse serum (M.O.M Kit, Vector
Laboratories, Peterborough, UK) in case of mouse-derived antibodies to avoid
labelling of endogenous mouse IgG. Sections were incubated with primary anti-
bodies (Supplementary Table 2) in blocking solution at 4 C overnight. Subsequent
to thorough washing, speciﬁc staining of antibody was revealed using species-
speciﬁc ﬂuorophore-conjugated secondary antibodies at RT for 1 h under light
protection. Sections were washed in PBS and counterstained using the ﬂuorescent
dye 40 ,6-diamidino-2-phenylindole (DAPI), applied at a concentration of
10mgml–1 at RT for 10min. Sections were washed with distilled water and
mounted in Aqua-Poly Mount. Images were captured using a confocal microscope
(SP8, Leica, Wetzlar, Germany). The number of marker-positive cells was
determined within the ﬁrst three cell layers adjacent to the ependyma and blotted
against the length of the ventricle. All analyses of virus-injected brains were
conducted in the hemisphere contralateral to the injection point. Statistical
analysis was performed using the unpaired, two-tailed t-test (Student’s t-test) or
Mann–Whitney U-test between EGFL7 and mock or WT groups.
Flow-cytometry analyses. Cell populations were identiﬁed by FACS as previously
described2,39,40,64. Animals were killed by cervical dislocation, brains were taken
out and the lateral SVZ was microdissected as a whole mount. To isolate striatal
neurons, tissue pieces similar to the SVZ whole-mount were microdissected from
the striatum upon SVZ removal. Pooled tissue (5 mice per sample) was digested
with Papain and DNAse as previously described2. Cells were stained for 20min on
ice in PBS using following antibodies: eFluor405-conjugated rat anti-mCD24
(1:100, BD Pharmingen, San Jose, CA, USA), rabbit anti-mGFAP (1:100, clone
G-A-5, Sigma), APC-conjugated rat anti-mGLAST (1:40, clone ACSA-1, Miltenyi,
Bergisch Gladbach, Germany), Rhodamine-complexed EGF (1:200, Molecular
Probes, Waltham, MA, USA) and eFluor710-conjugated rat anti-mCD133 (1:100,
clone 13A4, eBioscience, San Diego, CA, USA). All cell populations were isolated in
a single sort using a FACS Aria II (Becton Dickinson, Franklin Lakes, NJ, USA).
Data were analysed with FlowJo v9.6.2 software (Tree Star, Ashland, OR, USA). For
expression analysis cells were collected in RLT Buffer and RNA extraction was
performed as described above.
SILAC-based mass spectrometry. Neurosphere protein extracts derived from
control and EGFL7 / cultures were lysed in lysis buffer (4% SDS, 10mM
Tris-HCl, pH 7.5). Protein concentration was measured by the Bradford assay and
extracts were mixed in a 1:1 ratio with adult brain protein extracts derived of Lys(6)
(¼ 13C6 lysine)-labelled SILAC mice as an internal protein standard25. Proteins
were separated by SDS Page and in-gel digestion was performed as described65.
In brief, each gel lane was divided into equal parts and cut into 1mm2 cubes.
Subsequent to several wash steps, proteins were reduced with 10mM DTT at 56 C
for 30min and alkylated with IAA for 30min at RT in the dark. Gel pieces were
washed, dehydrated with ethanol and rehydrated using 50mM ammonium
bicarbonate. 40 ml of an 12 ng ml–1 trypsin solution was added and samples were
incubated overnight at 37 C. Generated peptides were extracted using an
increasing content of acetonitrile and were subsequently concentrated in a
vacuum concentrator. Before liquid chromatography tandem mass spectrometry
(LC-MS/MS) analysis, samples were desalted using STAGE tips66. Next, peptides
were eluted from C18 tips with 30 ml of 0.5% acetic acid in 80% acetonitrile,
concentrated in a vacuum concentrator and resuspended in 10 ml buffer A (0.5%
acetic acid). The LC-MS/MS equipment consisted of an EASY nLC system coupled
to the ion-trap based Orbitrap instrument (Thermo Scientiﬁc, Waltham, MA,
USA) by a nanospray electron ionization source (Orbitrap XL or Orbitrap Velos).
Peptides were separated on an in-house packed 30 cm column (3 mm C18 beads,
Dr A. Maisch GmbH, Ammerbuch-Entringen, Germany) using a binary buffer
system: A) 0.5% acetic acid and B) 0.1% acetic acid in acetonitrile. Peptides were
eluted in a gradient from 5% B to 37% B within 120min followed by a washing and
re-equilibration step. All settings for mass spectrometric analysis are described
elsewhere67. For raw data processing MaxQuant68 and the implemented
Andromeda search engine were used to correlate the recorded MS/MS spectra
against the mouse IPI database. FDR was estimated on the peptide-spectra-match
and protein level to 1% by a decoy database approach. Other settings were used as
previously described69.
Immunoprecipitation and immunoblotting. Transient transfection of HEK293
cells (ATCC, Middlesex, UK; cell line routinely mycoplasma tested) was performed
with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions.
A total of 3 mg of plasmid DNA was used to transfect cells. Immunoprecipitation
and immunoblotting were performed as previously described70. In brief, HEK293
cells were lysed in ice-cold lysis buffer containing protease and phosphatase
inhibitors. Following centrifugation at 16,200g for 10min, supernatants were
subjected to immunoprecipitation in the presence of 40 ml of Immunosorb A
(Medicago, Uppsala, Sweden) overnight at 4 C on a rotating platform. The
following day, the beads were washed 3 in lysis buffer and after centrifugation
the bead pellet was resuspended in 20 ml 4 Laemmli protein loading buffer and
boiled for 5min at 95 C. Immune complexes were loaded onto 10% SDS-
polyacrylamide gels and transferred to nitrocellulose membranes (GE Watter and
Process, Herentals, Belgium). Membranes were blocked in 10% blocking solution
(Rotiblock, Roth, Karlsruhe, Germany) overnight at 4 C. All primary antibody
incubations were performed in blocking buffer for 2 h at RT followed by incubation
with ﬂuorescent-labelled anti-mouse antibody for 1 h at RT. The following
antibodies were used: mouse anti-V5 (1:2,500, Biozol, Eching, Germany), mouse
anti-Flag M2 (1:5,000, Sigma, St. Louis, MI, USA), mouse anti-Tubulin alpha Ab-2
(1:6,000, Thermo Scientiﬁc), ﬂuorescent-labelled goat-anti mouse (1:15,000,
LI-COR Biosciences, Lincoln, NE, USA). Immunocomplexes were visualized by
ﬂuorescence using Odyssey (LI-COR Biosciences) according to the manufacturer’s
instruction. Image Studio Lite software v4.0 (LI-COR Biosciences) was used
for detection and densitometric analysis of western blot data according to
manufacturer’s instructions. Western blot images in Supplementary Fig. 3 have
been cropped for presentation. Full size images are presented in Supplementary
Fig. 7.
Statistical analysis. Statistical analyses were performed using GraphPad Prism 6.0
software (Statcon, Witzenhausen, Germany). One-way ANOVA, Student’s t-test
or the Mann–Whitney U-test were used for statistical analysis of usually three
biological replicates per experiment; group size was typically between 5 and 10;
Po0.05 was considered signiﬁcant. All experiments were conducted double
blinded. F-tests were used to compare variances between groups. Parametric
data were analysed using an unpaired two-tailed Student’s t-test, in the case of
non-parametric data the Mann–Whitney U-test was used instead. Alternatively,
one-factor ANOVA was used followed by post hoc analysis for comparisons
between three or more groups. Statistical methods used in the analysis are described
in ﬁgure legends or experimental procedures. No randomization was applied.
Data availability. All relevant data are available from the authors.
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